Concepedia

Melissa A. Wendt

MA

4

Publications

1.2K

Citations

4

H-Index

2001

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Melissa A. Wendt is an author at Beth Israel Deaconess Medical Center specializing in cell biology, medicine, and cancer cell biology.

Top concepts

Publications per year

2001–2003

4

Publications

4

Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.

Robin E. Bachelder, Aimeé M. Crago, Jun Chung et al. · PubMed · 2001 · 440 citations

, , +20

Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.

Robin E. Bachelder, Melissa A. Wendt, Arthur M. Mercurio · PubMed · 2002 · 429 citations

, , +15

Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells.

Robin E. Bachelder, Elizabeth A. Lipscomb, Xuena Lin et al. · PubMed · 2003 · 198 citations

, , +15

The Cleavage of Akt/Protein Kinase B by Death Receptor Signaling Is an Important Event in Detachment-induced Apoptosis

Robin E. Bachelder, Melissa A. Wendt, Naoya Fujita et al. · Journal of Biological Chemistry · 2001 · 98 citations · Full text

, , +20

Rows per page

1–4 of 4